Abiraterone Acetate is Used for the treatment of advanced prostate cancer in combination with prednisone, including metastatic castration-resistant and high-risk castration-sensitive types. It was first introduced by Janssen Biotech Inc in its drug Zytiga on Apr 28, 2011. Another drug containing Abiraterone Acetate is Yonsa. 15 different companies have introduced drugs containing Abiraterone Acetate.
Abiraterone Acetate Patents
Given below is the list of patents protecting Abiraterone Acetate, along
with the drug name that holds that patent and the company name owning that
drug.
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Abiraterone Acetate's patents.
Latest Legal Activities on Abiraterone Acetate's Patents
Given below is the list recent legal activities going on the following patents of Abiraterone Acetate.
Activity
Date
Patent Number
Payment of Maintenance Fee, 4th Year, Large Entity
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Abiraterone Acetate Generic API Manufacturers
Several generic applications have been filed for Abiraterone Acetate. The first generic version for Abiraterone Acetate was by Apotex Inc and was approved on Oct 31, 2018. And the latest generic version is by Msn Laboratories Private Ltd and was approved on Apr 24, 2024.
Given below is the list of companies who have filed for
Abiraterone Acetate generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL PHARMS
Amneal Pharmaceuticals Of New York Llc has filed for 2 different strengths of generic version for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Amneal Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
Jan 7, 2019
500MG
tablet
Prescription
ORAL
AB
Dec 23, 2020
2. APOTEX
Apotex Inc has filed for 1 generic for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Apotex.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
Oct 31, 2018
Manufacturing Plant Locations
New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
Country
City
Firm Name
United States
Weston
Apotex Corp.
Canada
Toronto
Apotex Inc.
Brantford
Apotex Pharmachem Inc.
Etobicoke
Apotex, Inc.
Winnipeg
Apotex Fermentation Inc.
North York
Apotex Inc.
Richmond Hill
Apotex Inc.
India
Bangalore
Apotex Pharmachem India Pvt Ltd.
Bangalore
Apotex Research Private Limited - Bioequivalence Centre
Bengaluru
Apotex Research Private Limited
3. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Dr Reddys.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
May 18, 2020
500MG
tablet
Prescription
ORAL
AB
Sep 1, 2023
4. FLORIDA
Florida Pharmaceutical Products Llc has filed for 1 generic for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Florida.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
500MG
tablet
Prescription
ORAL
AB
Mar 23, 2023
5. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 2 different strengths of generic version for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Glenmark Speclt.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
Oct 16, 2019
500MG
tablet
Prescription
ORAL
AB
May 19, 2022
6. HIKMA
Hikma Pharmaceuticals Llc has filed for 1 generic for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Hikma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
Oct 31, 2018
Manufacturing Plant Locations
New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country
City
Firm Name
United States
Dayton
Hikma Injectables USA Inc
Cherry Hill
Hikma Pharmaceuticals USA Inc.
Eatontown
Hikma Pharmaceuticals USA, Inc.
Carlsbad
Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt
Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman
Hikma Pharmaceuticals LLC
7. MSN
Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Msn.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
Jul 10, 2019
500MG
tablet
Prescription
ORAL
AB
Apr 24, 2024
Manufacturing Plant Locations
New
Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Mylan.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
Oct 31, 2018
500MG
tablet
Prescription
ORAL
AB
Dec 14, 2020
Manufacturing Plant Locations
New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
Country
City
Firm Name
United States
Rockford
Mylan Institutional, Inc.
Santa Barbara
Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
San Carlos
Mylan Pharmaceuticals Inc.
Morgantown
MYLAN CONSUMER HEALTHCARE Inc.
Morgantown
Mylan Specialty, L.P.
Saint Albans
Mylan Technologies, Inc.
Greensboro
Mylan Pharmaceuticals Inc
India
Hyderabad
Mylan Laboratories Limited
Sarigam
Mylan Laboratories Limited
Bangalore
Mylan Laboratories Limited
Anekal Taluk, Bangalore
Mylan Laboratories Limited
Pithampur, District Dhar
Mylan Laboratories Limited
Sinnar
Mylan Laboratories Limited
Hosur
Mylan Laboratories Limited
Aurangabad
Mylan Laboratories Limited (FDF-2)
Canada
Etobicoke
Mylan Pharmaceuticals ULC
Ireland
Inverin
Mylan Teoranta
9. NOVUGEN
Novugen Oncology Sdn Bhd has filed for 2 different strengths of generic version for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Novugen.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
Jan 5, 2022
500MG
tablet
Prescription
ORAL
AB
Jan 5, 2022
10. QILU
Qilu Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Qilu.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
Sep 27, 2019
500MG
tablet
Prescription
ORAL
AB
Jun 25, 2021
Manufacturing Plant Locations
New
Qilu's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Qilu as present at those locations.
Country
City
Firm Name
China
Jinan
Qilu Antibiotics Pharmaceutical Co. , Ltd.
Hohhot
Qilu Pharmaceutical (Inner Mongolia) Co., Ltd.
Dezhou
Qilu SYNVA Pharmaceutical Co. Ltd
Haikou
Qilu Pharmaceutical (Hainan) Co. Ltd.
Jinan
Qilu Pharmaceutical Co., Ltd.
Jinan
Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
Hulunbeier
Qilu Pharmaceutical Hulun Buir Branch
11. RISING
Rising Pharma Holdings Inc has filed for 1 generic for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Rising.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
Feb 25, 2019
Manufacturing Plant Locations
New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
Country
City
Firm Name
United States
Phoenix
Rising Sun Farms Inc
Fort Bragg
Rising Tide Sea Vegetables
Saddle Brook
Rising Pharmaceuticals, Inc.
Decatur
Rising Pharma Holdings, Inc
Livingston
Risingsun Iodine Products Corp.
East Brunswick
Rising Pharma Holding, Inc.
Mount Morris
Rising Creek Bakery LLC
Rising Sun
Rising Sun Veterinary Clinic
Flagstaff
Rising High Enterprises, LLC (DBA RisingHy)
Mexico
Pueblo San Clemente
RISING FARMS SAPI DE CV
India
Ahmedabad
Rising Retina Clinic
12. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Teva Pharms Usa.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
250MG
tablet
Prescription
ORAL
AB
Oct 31, 2018
125MG
tablet
Discontinued
ORAL
N/A
Jun 24, 2022
500MG
tablet
Prescription
ORAL
AB
Jan 26, 2023
13. WOCKHARDT BIO AG
Wockhardt Bio Ag has filed for 1 generic for Abiraterone Acetate. Given below are the
details of the strengths of this generic introduced by
Wockhardt Bio Ag.
